Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase‐2 inhibitor
- 30 May 2016
- journal article
- case report
- Published by Wiley in International Journal of Urology
- Vol. 23 (8) , 706-708
Abstract
Cystitis glandularis, a proliferative disease of the bladder, is resistant to antibiotics, non-steroidal anti-inflammatory drugs, anti-allergy drugs and transurethral resection. Cystectomy or partial cystectomy is occasionally required for refractory cystitis glandularis. It has not been defined if cystitis glandularis is a premalignant lesion. We experienced a case of remission from cystitis glandularis after combination of oral treatment with selective cyclooxygenase-2 inhibitor, celecoxib and transurethral resection. Immunohistochemistry showed positive signals of cyclooxygenase-2 in the epithelium of pretreatment specimens, suggesting the pathophysiological role of cyclooxygenase-2 in cystitis glandularis. Here, we show the effectiveness of celecoxib against cystitis glandularis for the first time. Celecoxib could be one of the therapeutic strategies for cystitis glandularis.Keywords
This publication has 10 references indexed in Scilit:
- Cyclooxygenase-2 and B-cell lymphoma-2 expression in cystitis glandularis and primary vesicle adenocarcinomaBMC Urology, 2014
- Expression and Functional Role of Cdx2 in Intestinal Metaplasia of Cystitis GlandularisJournal of Urology, 2013
- A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancerBreast Cancer Research, 2013
- Cyclooxygenase, Cancer Stem Cells and DNA Methylation Play Important Roles in Colorectal CarcinogenesisDigestion, 2013
- Glandular lesions of the urinary bladder:clinical significance and differential diagnosisHistopathology, 2010
- Role of Cystitis Cystica et Glandularis and Intestinal Metaplasia in Development of Bladder CarcinomaUrology, 2008
- Expression of Cyclooxygenase-2 in Normal Urothelium, and Superficial and Advanced Transitional Cell Carcinoma of BladderJournal of Urology, 2007
- Celecoxib for the Prevention of Sporadic Colorectal AdenomasNew England Journal of Medicine, 2006
- Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladderLaboratory Investigation, 2006
- Intestinal metaplasia is not a strong risk factor for bladder cancer: Study of 53 cases with long-term follow-upUrology, 1997